MDS

Raising the Bar for Myelofibrosis Therapy Development Bookmark

Article from MedPage Today curated by Contributing Editor George Lundberg, MD, who notes: 

Myelodysplastic syndrome (MDS) commonly occurs before a patient develops acute leukemia, and is largely unresponsive to therapy. Two new clinical trials are entering phase 3 and may offer some hope.

.